Quality Improvement Project- Sitting out of Older Patients on chair in the ward at General Hospital, Chester
Introduction Sitting out of bed plays a crucial role in preventing deconditioning, muscle wasting, pressure injuries and thrombosis among older inpatients. It also fosters social interaction and cognitive engagement, reducing hospital stay duration and combating 'PJ Paralysis'. Objective To improve the number of older patients sitting out of bed during lunchtime in the COTE ward, thereby supporting their functional recovery and overall well-being. Methods Direct observations were conducted over two consecutive days at baseline and again three weeks after intervention were implemented. Patients
“Let’s Talk Research” – Improving Older Adults’ Understanding of Opportunities for Research Involvement
Utilisation Of FRAX Tool For Primary Prevention Of Fragility Fracture In Older Person Assessment Unit At Morriston Hospital
Improving Stroke Induction Information for Resident Doctors in a District General Hospital: A Quality Improvement Project
Falls, frailty and fractures - Adherence of the Acute Medical Unit to Guidelines
Are NHS Junior Doctors Requesting CT Scans Appropriately? Evaluating Compliance with Royal College Guidelines for CT Scan Requests
Rationalising Blood Tests in the Elderly: An Audit of Routine Blood Investigation Requests in Geriatric Wards
Improving the appropriateness of polypharmacy reviews during hospital admissions: A three-stage retrospective quality improvement project
Introduction: Inappropriate polypharmacy is the use of medications with no evidence-based indication, unmet treatment goals, high risk of adverse drug reactions, or when the patient is unwilling / unable to take treatment as intended. This is particularly concerning in geriatric care, due to increased risk of hospital admissions, adverse drug reactions and significant healthcare costs. To address these risks, clinicians should conduct patient-focused medication reviews. This project aimed to assess and improve polypharmacy reviews at Royal Albert Edward Infirmary (RAEI), with a focus on
Use of Intravenous Furosemide in Patients Presenting with Symptoms of Acute Heart Failure in the Acute Setting: A Quality Improvement Project
Quality Improvement Project Assessment of PAIN in Acute and Frailty Geriatrics in-patients at a district Hospital in South Wales
The motor profile of patients with idiopathic Parkinson’s disease in the Hai district of northern Tanzania
Introduction Parkinson’s disease (PD) is the second most common neurodegenerative condition globally. Its cardinal motor signs are bradykinesia, rest tremor, rigidity, and postural instability. The motor symptoms of PD often lead to dependence on others to perform daily activities. Globally, the incidence of PD is rising. However, for countries in sub-Saharan-Africa such as Tanzania, research on the motor aspects of PD and the associated disability is sparse. The primary aim of this study was to determine the motor symptoms, and burden of motor symptoms, in newly diagnosed people with
Readmissions after Frailty Emergency Squad discharge in the Emergency Department
INTRODUCTION The increasing prevalence of frailty in the ageing UK population poses significant challenges for healthcare systems, particularly in emergency departments (EDs). Frailty is a leading factor in hospital readmissions among individuals over 65 years old. This project aims to analyze readmissions of frail patients within 7 and 30 days of ED discharge following comprehensive geriatric assessments (CGAs). METHOD This retrospective audit aimed to identify 7 day and 30 day readmissions of patients discharged by the Frailty Emergency Service (FES) at Leicester Royal Infirmary over a six
DIAGNOSTIC ABILITY OF SARC-F ACCORDING TO MUSCLE STRENGTH AND PHYSICAL PERFORMANCE TESTS
Background: Sarcopenia, a prevalent geriatric syndrome with multifactorial origins, is strongly influenced by malnutrition alongside immobility and chronic illness and contributes substantially to falls, disability, and mortality. The SARC-F (Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls) questionnaire is widely used to screen for probable sarcopenia; however, the conventional cut-off of ≥4 has yielded insufficient sensitivity across studies. Objective: To evaluate how SARC-F scores correspond to muscle strength and physical performance tests endorsed by the
Does the frailty index applied to randomised controlled trials really measure frailty?
Background Cumulative deficit frailty indices from randomised controlled trials (RCT) are increasingly used to assess whether trial findings are applicable to people living with frailty. The aim of this study was to examine the range and type of deficits included in these frailty indices and compare these to those from cohort studies. Methods We identified RCTs assessing treatment effect modification using the cumulative deficit frailty index, as well as cohort studies assessing mortality risk associated with frailty, from recent systematic reviews. We extracted the deficits included in the
Polypharmacy and potentially inappropriate prescribing in type 2 diabetes: A nationally comprehensive analysis of Scottish data
Aims This study assesses national trends and, sociodemographic and clinical factors associated with polypharmacy and potentially in appropriate prescribing among people with type 2 diabetes in Scotland from 2012 to 2022. Methods Retrospective cohort study using nationwide data from the Scottish Care Information – Diabetes database. Individuals aged ≥40 years with type 2 diabetes were included. Medication counts were based on unique medications dispensed per calendar year. Potentially inappropriate medications were based on the 2023 Beers criteria and applied to people aged over 65 years. A
Comparing age, comorbidity and event rates between SGLT2 inhibitor trial participants and people treated in routine care
Background Randomised controlled trials are often criticised for excluding older people with multiple long-term conditions. This study used individual participant data (IPD) for 25 trials of sodium glucose co-transporter-2 inhibitors (SGLT2i) to compare baseline characteristics, comorbidities, and event rates between trial participants and community SGLT2i-treated people. Methods Trials were identified through a systematic review with subsequent application for IPD. Community SGLT2i-treated people in routine care were identified from SAIL databank. For each trial, we applied the eligibility